OGN
CompareOrganon & Company
Exchange: NYSESector: HealthcareIndustry: Drug Manufacturers - General
Organon & Company
Did you know?
Trading 31% above its estimated fair value of $7.77.
Current Price
$11.26
+30.93%GoodMoat Value
$7.77
31.0% overvaluedProfile
Valuation (TTM)
Market Cap$2.93B
P/E15.65
EV$9.65B
P/B3.89
Shares Out259.98M
P/Sales0.47
Revenue$6.22B
EV/EBITDA8.53
Organon & Company (OGN) — Earnings Call Transcripts
19 earnings call transcripts available.
Latest Transcript
Read →Q4 2025 Earnings Call
12 speakers5,269 words29 segments